SLD — Saluda Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$894.68m
- AU$820.00m
- $90.18m
Annual cashflow statement for Saluda Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -92.2 | -97.8 | -149 | -150 |
| Depreciation | ||||
| Non-Cash Items | 11.8 | 8.54 | 43.6 | 24.3 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -7.58 | -6.66 | -15.1 | 6.38 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -85.7 | -93.3 | -118 | -116 |
| Capital Expenditures | -2.37 | -1.08 | -1.27 | -0.741 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -2.37 | -1.08 | -1.27 | -0.741 |
| Financing Cash Flow Items | — | — | — | -10.5 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 144 | -0.284 | 97.9 | 181 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 55.1 | -94.9 | -17.3 | 64.1 |